Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRANIT: Efficacy and Safety of Velsecorat (AZD7594) in Asthma
NCT03622112Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of velsecorat in asthma, sponsored by AstraZeneca. Started Jan 2019; status: completed.
02
Drugs
velsecorat
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03622112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03622112.